Recovery from daily-life stressors in early and chronic psychosis.

Adult Affective Symptoms / physiopathology Chronic Disease Ecological Momentary Assessment Female Humans Male Psychotic Disorders / physiopathology Risk Schizophrenia / physiopathology Stress, Psychological / physiopathology Young Adult
At-risk mental state Ecological momentary assessment First-episode psychosis Recovery Schizophrenia Stress

Journal

Schizophrenia research
ISSN: 1573-2509
Titre abrégé: Schizophr Res
Pays: Netherlands
ID NLM: 8804207

Informations de publication

Date de publication:
11 2019
Historique:
received: 05 11 2018
revised: 10 03 2019
accepted: 13 03 2019
pubmed: 2 4 2019
medline: 15 9 2020
entrez: 2 4 2019
Statut: ppublish

Résumé

Initial affective and psychotic reactivity to daily stressors is altered in psychosis, and most notably in early psychosis. In addition to altered initial stress reactivity, results from studies using Experience Sampling Methodology (ESM) and psychophysiological measures indicate that impaired recovery from mild stressors may also be a risk factor for mental illness. The current ESM study investigated affective recovery from daily stressors in chronic psychosis patients (CP; n = 162), individuals at early stages of psychosis (EP; n = 127), and healthy volunteers (HV; n = 220) assessing fluctuations in negative affect (NA), tension, and suspiciousness ten times a day on six consecutive days. Recovery was operationalized for all three variables as the return to baseline (i.e., level at t

Identifiants

DOI: 10.1016/j.schres.2019.03.011 PMID: 30930036
pubmed: 30930036
pii: S0920-9964(19)30105-7
doi: 10.1016/j.schres.2019.03.011
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

32-39

Subventions

Organisme : Medical Research Council
ID : MR/J008915/1
Pays : United Kingdom

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Thomas Vaessen (T)

Department of Neurosciences, Center for Contextual Psychiatry, KU Leuven, Leuven, Belgium; Department of Neurosciences, Mind-Body Research Group, KU Leuven, Leuven, Belgium. Electronic address: thomas.vaessen@kuleuven.be.

Wolfgang Viechtbauer (W)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands; Department of Neurosciences, Center for Contextual Psychiatry, KU Leuven, Leuven, Belgium.

Yori van der Steen (Y)

GGzE, Institute for Mental Health Care Eindhoven and De Kempen, Eindhoven, the Netherlands; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.

Charlotte Gayer-Anderson (C)

Centre for Epidemiology and Public Health, Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, UK.

Matthew J Kempton (MJ)

Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, UK.

Lucia Valmaggia (L)

Department of Psychology, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, UK; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust and King's College, London, UK.

Philip McGuire (P)

Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, UK; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust and King's College, London, UK.

Robin Murray (R)

Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, UK; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust and King's College, London, UK.

Philippa Garety (P)

Department of Psychology, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, UK; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust and King's College, London, UK.

Til Wykes (T)

Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, UK; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust and King's College, London, UK.

Craig Morgan (C)

Centre for Epidemiology and Public Health, Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, UK; National Institute for Health Research (NIHR) Mental Health Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust and King's College, London, UK.

Tineke Lataster (T)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.

Johan Lataster (J)

Faculty of Psychology and Educational Sciences, Open University, Heerlen, the Netherlands; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.

Dina Collip (D)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.

Dennis Hernaus (D)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.

Zuzana Kasanova (Z)

Department of Neurosciences, Center for Contextual Psychiatry, KU Leuven, Leuven, Belgium.

Philippe Delespaul (P)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.

Margreet Oorschot (M)

Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, the Netherlands.

Stephan Claes (S)

Department of Neurosciences, Mind-Body Research Group, KU Leuven, Leuven, Belgium.

Ulrich Reininghaus (U)

Department of Public Mental Health, Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg, Germany; Centre for Epidemiology and Public Health, Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College, London, UK.

Inez Myin-Germeys (I)

Department of Neurosciences, Center for Contextual Psychiatry, KU Leuven, Leuven, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Recovery from daily-life stressors in early...
questionsmedicales.fr › Comportement et mécanismes comportementaux › Comportement › Symptômes comportementaux › Symptômes affectifs › Recovery from daily-life stressors in early...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Maladie chronique › Recovery from daily-life stressors in early...
questionsmedicales.fr › Disciplines et activités comportementales › Tests psychologiques › Évaluation écologique instantanée › Recovery from daily-life stressors in early...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Recovery from daily-life stressors in early...
questionsmedicales.fr › Troubles mentaux › Schizophrénie et troubles avec traits psychotiques › Troubles psychotiques › Recovery from daily-life stressors in early...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Statistiques comme sujet › Probabilité › Risque › Recovery from daily-life stressors in early...
questionsmedicales.fr › Troubles mentaux › Schizophrénie et troubles avec traits psychotiques › Schizophrénie › Recovery from daily-life stressors in early...
questionsmedicales.fr › Phénomènes psychologiques › Stress psychologique › Recovery from daily-life stressors in early...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Jeune adulte › Recovery from daily-life stressors in early...